Gaudium IVF and Women Health Limited
Gaudium IVF and Women Health Limited (GAUDIUMIVF): company summary
The company's annual revenue rose 47.0% to ₹104 crore, while annual net profit increased 28.7% to ₹24 crore.
Gaudium IVF and Women Health Limited (GAUDIUMIVF) is a micro-cap Healthcare company valued at ₹740 crore operating in Healthcare Service Provider on the NSE and BSE.
- Recent price move
- Gaudium IVF and Women Health Limited last traded at ₹101.7, modestly down 1.05% on the day.
- Recent developments
- On 2026-07-15, the company announced the commencement of commercial operations at its new IVF Centre/Hub in South Extension, New Delhi, marking a key expansion step for its services.
- Financial performance
- The company's annual revenue rose 47.0% to ₹104 crore, while annual net profit increased 28.7% to ₹24 crore. However, the net profit margin narrowed 3.3 percentage points to 23.4%, and the latest quarter saw net profit fall 42.0% to ₹2 crore despite revenue rising 9.1% to ₹19 crore.
- Valuation multiples
- The stock trades at 30.3 times earnings, broadly in line with the Healthcare median of 32.0, 5.47 times book value.
- Things to watch
- The company's net profit margin has declined, and the latest quarter's net profit dropped significantly. The stock is 32.9% below its 52-week high, and the company has not paid dividends despite reporting profits.
- Where it stands
- The company has seen strong revenue growth over the past three years, but its net profit margin has narrowed. The latest quarter's net profit fell sharply, and the stock is trading below its 52-week high. The company's promoter holds 71.29% of the shares.
Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by risk (7.5) and growth (7.2), but held back by valuation (2.2). Risk looks strong at 7.5, but that is offset by valuation at 2.2 and momentum at 2.8. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Revenue compounding 33% a year
- Low leverage — D/E 0.16
- Profitable in all of the last 5 years
- Valuation is weak (2.2/10)
- Small ₹740 cr company — thinner liquidity
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Healthcare Service Provider
Explore Gaudium IVF and Women Health Limited’s valuation
Free deep-dive tools · no sign-up
Gaudium IVF and Women Health Limited peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare Gaudium IVF and Women Health Limited with peers
Related tools & concepts
Value Gaudium IVF and Women Health Limited with the ratios and calculators DocStoX uses in its analysis.

